https://pmc.ncbi.nlm.nih.gov/articles/PMC11836434/
CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia - PMC
Metabolic reprogramming and cell cycle deregulation are hallmarks of cancer cells. The cell cycle kinase CDK6 has recently been implicated in a wide range of...
bcr abl1cdk6kinaseinhibitionunmasks
https://www.wikidata.org/wiki/Q81060463
e6-a2 BCR-ABL1 fusion in T-cell acute lymphoblastic leukemia - Wikidata
scientific article published on 01 February 2005
acute lymphoblastic leukemiabcr abl1
https://pmc.ncbi.nlm.nih.gov/articles/PMC12951377/
BCR::ABL1 Mutational Profiling in US Patients With Chronic-phase Chronic Myeloid Leukemia on...
Widespread use of BCR::ABL1 tyrosine kinase inhibitors (TKIs) has transformed the clinical landscape of chronic myeloid leukemia (CML). However, BCR::ABL1...
https://medcraveonline.com/IJFCM/variant-p190-of-the-bcr-abl1-gene-in-a-pediatric-patient-with-chronic-myeloid-leukemia.html
Variant p190 of the BCR-ABL1 gene in a pediatric patient with chronic myeloid leukemia - MedCrave...
Chronic myeloid leukemia is a clonal disease characterized by the overproduction of cells of the myeloid lineage, this entity affects mainly adults, describing...
https://pmc.ncbi.nlm.nih.gov/articles/PMC5240017/
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the...
Molecular monitoring of chronic myeloid leukemia patients using robust BCR-ABL1 tests standardized to the International Scale (IS) is key to proper disease...
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1393191/full
Frontiers | Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase...
Tyrosine kinase inhibitors (TKI) have revolutionized the treatment of patients with chronic myeloid leukemia. Patients who achieve sustained deep molecular r...